Delivery Order SPE2DB24D9238-SPE2DB25FDQLX

Award Date 1/31/25
Potential Completion Date 2/24/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,761.76 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to support the recurring medical supply needs of military health facilities worldwide. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,626.96 firm fixed-price delivery order contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with DLA under the SPE2DB program, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,567.40 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a branded pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,313.48 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a period of performance through August 26, 2024. This award is part of a larger indefinite delivery contract (IDC) under the DLA's SPE2DB program, valued at up to $499,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,583.86 firm fixed-price delivery order is for the supply of EYLEA 2MG/0.05ML SY 1S, a pharmaceutical product, with a performance period through September 6, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,008.00 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $81,618.90 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,540.68 firm fixed-price contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of April 18, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB25FDQLX
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,540.68 firm fixed-price delivery order is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product.

The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This IDC, which is valid through November 2026, covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories. As a prime contractor, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA, including specialized medications used in oncology, contraception, and other medical domains.

Generated 5/4/25, 12:52 AM